menu search

Construction equipment market expected to reach usd 2,61,226.4 million by 2030, with a cagr of 7.75% – report by market research future (mrfr)

Construction Equipment Market Information by Type (Excavator, Crawler Excavators, Mini Excavators, Loaders, Wheeled Loaders, Dozers, Skid Steer Loader...

March 3, 2023, 4:29 pm

Global motor grader market to worth $36b by 2030 with expanding construction and mining sectors

NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) — Here are some interesting insights from a new report on the global motor grade and leveller market publis...

February 1, 2023, 2:12 pm

C4 therapeutics announces first patient dosed in phase 1/2 clinical trial evaluating cft1946, an orally bioavailable bidac™ degrader, in braf v600 mutant solid tumors

WATERTOWN, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated ...

January 30, 2023, 12:00 pm

Salarius pharmaceuticals to present sp-3164 targeted protein degrader preclinical data at the inaugural molecular glue drug development summit

Dr. Aundrietta Duncan to discuss mechanism of action and SP-3164 activity in cancer models Company planning to submit an Investigational New Drug appl...

January 19, 2023, 1:30 pm

Salarius pharmaceuticals to present sp-3164 targeted protein degrader preclinical data at the inaugural molecular glue drug development summit

Dr. Aundrietta Duncan to discuss mechanism of action and SP-3164 activity in cancer models...

January 19, 2023, 8:30 am

Nurix therapeutics advances promising targeted protein modulation pipeline and outlines 2023 strategic priorities

Nurix leads targeted protein modulation field with its wholly owned clinical stage programs and two strategic collaborations fueled by its DELigase pl...

January 9, 2023, 1:35 pm

Ccor: strong buy rating, based on its unique risk-management approach

CCOR might just be the best ETF around for those who prioritize risk-management during this crazy investment era. I try to be a tough ...

December 27, 2022, 2:48 pm

Nurix therapeutics presents positive clinical results from its novel btk degrader (nx-2127) at the 64th american society of hematology (ash) annual meeting

Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients regardless of Bruton...

December 12, 2022, 10:30 pm

Kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

Kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

Kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

Kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

Kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

Nurix therapeutics announces webcast to review data from its phase 1 clinical trial of btk degrader, nx-2127, presented at the 64th american society of hematology annual meeting

Webcast Scheduled for Monday, December 12, 2022 at 8:30 PM CT (9:30 PM ET) Webcast Scheduled for Monday, December 12, 2022 at 8:30 PM CT (9:30 PM ET)...

December 7, 2022, 4:01 pm

The 7 highest dividend stocks for income investors

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend ...

February 9, 2022, 2:36 pm

The 7 highest dividend stocks for income investors

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend ...

February 9, 2022, 2:36 pm

The 7 highest dividend stocks for income investors

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend ...

February 9, 2022, 2:36 pm

Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals

Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into...

November 23, 2021, 12:18 am

Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals

Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into...

November 23, 2021, 12:18 am

Shell builds singapore pyrolysis oil unit to convert plastic waste to chemicals

Royal Dutch Shell said on Tuesday it plans to build a pyrolysis oil upgrader to turn plastic waste into...

November 23, 2021, 12:18 am


Search within

Pages Search Results: